Government Decree No. 11 / 2025 Coll.
Government regulation on the list of classified psychoactive substances
Valid
Effective from 17.01.2025
11
GOVERNMENT REGULATION
of 18 December 2024
on the list of psychoactive substances included
The Government hereby orders pursuant to § 44c (3) (b) to implement § 33k (6) of Act No. 167 / 1998 Coll., on addictive substances and amending certain other laws, as amended by Act No. 321 / 2024 Coll.:
Subject matter
This Regulation establishes a list of classified psychoactive substances as set out in the Annex to this Regulation.
Notification of technical regulation
This Regulation was notified in accordance with Directive (EU) 2015 / 1535 of the European Parliament and of the Council of 9 September 2015 laying down a procedure for the provision of information in the field of technical standards and regulations and of rules on information society services.
Efficacy
This Regulation shall enter into force on the day following that of its publication.
Prime Minister:
Prof. PhDr. Fiala, Ph.D., LL.M., v. r.
Deputy Prime Minister and Minister for Health:
Prof. MUDr. Válek, CSc., MBA, EBIR, v. r.
Annex
List of classified psychoactive substances
| Mezinárodní nechráněný název (INN) v českém jazyce | Další mezinárodní nechráněný název nebo obecný název | Chemický název podle IUPAC | Popis | Poznámka |
|---|---|---|---|---|
| Hexahydrokanabiforol | HHCP | 6,6,9-trimethyl-3-heptyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol | ||
| Hexahydrokanabihexol | HHCH; HHC-C6 | 6,6,9-trimethyl-3-hexyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol | ||
| Hexahydrokanabinol | HHC | (6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol | S výjimkou látky HHC, pokud je obsažena v rostlině technického konopí, technickém konopí, konopí extrakt a tinktura a přípravku z technického konopí v nevyhnutelně se vyskytujícím přirozeném stopovém množství. Tato výjimka se nevztahuje na potraviny. | |
| Hexahydrokanabioktyl | HHC-C8 | 6,6,9-trimethyl-3-oktyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol | ||
| Hexahydrokanabutol | HHCB; HHC-C4 | 6,6,9-trimethyl-3-butyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol | ||
| Tetrahydrokanabiforol | THCP | (6aR,10aR)-3-heptyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol | S výjimkou látky THCP, pokud je obsažena v rostlině technického konopí, technickém konopí, konopí extrakt a tinktura a přípravku z technického konopí v nevyhnutelně se vyskytujícím přirozeném stopovém množství. Tato výjimka se nevztahuje na potraviny. | |
| Tetrahydrokanabihexol | THCH; THC-H6 | (6aR,10aR)-3-hexyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol | Včetně delta-8 izomeru. S výjimkou látky THCH, pokud je obsažena v rostlině technického konopí, technickém konopí, konopí extrakt a tinktura a přípravku z technického konopí v nevyhnutelně se vyskytujícím přirozeném stopovém množství. Tato výjimka se nevztahuje na potraviny. | |
| Tetrahydrokanabioktyl | THC-C8 | (6aR,10aR)-3-oktyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol | Včetně delta-8 izomeru. | |
| Tetrahydrokanabutol | THCB; THC-C4 | (6aR,10aR)-3-butyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol | Včetně delta-8 izomeru. S výjimkou látky THCB, pokud je obsažena v rostlině technického konopí, technickém konopí, konopí extrakt a tinktura a přípravku z technického konopí v nevyhnutelně se vyskytujícím přirozeném stopovém množství. Tato výjimka se nevztahuje na potraviny. | |
| 5-Methylthiopropamin | 1-(5-methylthiofen-2-yl)propan-2-amin | |||
| BOH-PHP | 1-fenyl-2-(pyrrolidin-1-yl)hexan-1-ol | |||
| M-ALPHA-HCMA | 3-(2H-1,3-benzodioxol-5-yl)-2-hydroxy-N,2-dimethyl-3-(methylamino)propanamid | |||
| Mefedren | N-methyl-1-(5-methyl-2-thienyl)propan-2-amin | |||
| 2-Fluor-deschlor-N-ethylketamin | 2-(ethylamino)-2-(2-fluorfenyl)cyklohexanon | |||
| 3-Cl-PCP | 1-[1-(3-chlorfenyl)cyklohexyl]piperidin | |||
| 3F-PCP | 1-[1-(3-fluorfenyl)cyklohexyl]piperidin | |||
| 3-Me-PCP | 1-[1-(3-methylfenyl)cyklohexyl]piperidin | |||
| 3-Me-PCPy | 1-[1-(3-methylfenyl)cyklohexyl]pyrrolidin | |||
| Deoxymethoxetamin | 2-(ethylamino)-2-(3-methylfenyl)-cyklohexanon | |||
| Fluorexetamin | 2-(ethylamino)-2-(3-fluorfenyl)cyklohexan-1-on | |||
| Hydroxetamin | 2-(ethylamino)-2-(3-hydroxyfenyl)-cyklohexanon | |||
| Methoxisopropamin | 2-(isopropylamino)-2-(3-methoxyfenyl)cyklohexanon | |||
| 4'-Chlordeschloralprazolam | 6-(4-chlorfenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepin | |||
| Bretazenil | 1,1-dimethylethyl 8-brom-11,12,13,13a-tetrahydro-9-oxo-9H-imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepin-1-karboxylát | |||
| Desalkylgidazepam | 7-brom-5-fenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | |||
| Deschlorklotizolam | 2-chlor-9-methyl-4-fenyl-6H-thieno[3,2-f][1,2,4]triazol[4,3-a][1,4]diazepin | |||
| Flubrotizolam | 2-brom-4-(2-fluorfenyl)-9-methyl-6H-thieno[3,2-f][1,2,4] triazolo [4,3-a][1,4]diazepin | |||
| Fluetizolam | 2-ethyl-4-(2-fluorfenyl)-9-methyl-6H-thieno[3,2-f][1,2,4] triazolo[4,3-a][1,4]diazepin | |||
| 6-BR-DMPEA | 2-brom-4,5-dimethoxyfenethylamin | |||
| N-pyrrolidinyl-3,4-DMA | 1-[2-(3,4-dimethoxyfenyl)-1-methylethyl]-pyrrolidin | |||
| PEAP | N-ethyl-1-fenylpentan-2-amin | |||
| 2-(4-Methylpiperazin-1-yl)-1-fenyl propan-1-on | 2-(4-methylpiperazin-1-yl)-1-fenylpropan-1-on | |||
| 2-MEB | 2-(ethylamino)-1-(2-methylfenyl)butan-1-on | |||
| 2'-Me-PVP | 1-(2-methylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | |||
| 2-Methyl-α-PHiP | 4-methyl-1-(2-methylfenyl)-2-(pyrrolidin-1-yl) pentan-1-on | |||
| 3,4-Pr-PipVP | 1-(2,3-dihydro-1H-inden-5-yl)-2-(piperidin-1-yl) pentan-1-on | |||
| 3F-NEB | 2-(ethylamino)-1-(3-fluorfenyl)butan-1-on | |||
| 3F-N-ethylhexedron | 2-(ethylamino)-1-(3-fluorfenyl)hexan-1-on | |||
| 3F-α-PHP | 1-(3-fluorfenyl)-2-(pyrrolidin-1-yl)hexan-1-on | |||
| 3-Chlorkathinon | 2-amino-1-(3-chlorfenyl)propan-1-on | |||
| 3'-Me-PVP | 1-(3-methylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | |||
| 3-Methyl-N-propyl-kathinon | 2-(propylamino)-1-(3-methylfenyl)-1-propanon | |||
| 4’-Methylhexedron | 2-(methylamino)-1-(4-methylfenyl)-1-hexanon | |||
| 4-Cl-3-MMC | 1-(4-chlor-3-methylfenyl)-2-(methylamino)propan-1-on | |||
| 4F-3-methyl-α-PHP | 1-(4-fluor-3-methylfenyl)-2-pyrrolidin-1-yl-hexan-1-on | |||
| 4F-3-methyl-α-PVP | 1-(4-fluor-3-methylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | |||
| MDPEP | 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)heptan-1-on | |||
| MDPHiP | 1-(1,3-benzodioxol-5-yl)-4-methyl-2-pyrrolidin-1-yl-pentan-1-on | |||
| N,N-diethylpentylon | 1-(1,3-benzodioxol-5-yl)-2-(diethylamino)pentan-1-on | |||
| N-butylbutylon | 1-(2H-1,3-benzodioxol-5-yl)-2-(butylamino)butan-1-on | |||
| N-cyklohexyl butylon | 1-(1,3-benzodioxol-5-yl)-2-(cyklohexylamino)butan-1-on | |||
| N-cyklohexyl methylon | 1-(1,3-benzodioxol-5-yl)-2-(cyklohexylamino)propan-1-on | |||
| N-ethylheptylon | 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)heptan-1-on | |||
| N-ethylhexylon | 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)hexan-1-on | |||
| N-sec-butyl-pentedron | 2-[(butan-2-yl)amino]-1-fenylpentan-1-on | |||
| α-D2PV | 1,2-difenyl-2-(pyrrolidin-1-yl)ethan-1-on | |||
| α-PCYP | 2-cyklohexyl-1-fenyl-2-(pyrrolidin-1-yl)ethan-1-on | |||
| 3-Chlorfenmetrazin | 2-(3-chlorfenyl)-3-methylmorfolin | |||
| 3-Methoxyfenmetrazin | 2-(3-methoxyfenyl)-3-methylmorfolin | |||
| 4Br-MAR | 5-(4-bromfenyl)-4-methyl-4,5-dihydro-1,3-oxazol-2-amin | |||
| 4Cl-MAR | 5-(4-chlorfenyl)-4-methyl-4,5-dihydro-1,3-oxazol-2-amin | |||
| 4-Fluorfenibut | 4-amino-3-(4-fluorfenyl)butanoát | |||
| Dichlormetakvalon | 5-chlor-3-(4-chlor-2-methylfenyl)-2-methyl-4(3H)-chinazolinon | |||
| Ephinazon | 2-ethyl-3-fenylchinazolin-4(3H)-on | |||
| Fenozolon | 2-(ethylamino)-5-fenyl-4(5H)-oxazolon | |||
| Iso-(meta-methyl-propkathinon) | 1-(3-methylfenyl)-1-(propylamino)propan-2-on | |||
| Iso-3-CMC | 1-(3-chlorfenyl)-1-(methylamino)propan-2-on | |||
| Iso-3-MMC | 1-(methylamino)-1-(3-methylfenyl)propan-2-on | |||
| N-ethyl zolpidem | N-ethyl-2-[6-methyl-2-(4-methylfenyl)imidazo[1,2-a]pyridin-3-yl]acetamid | |||
| Nitrometakvalon | 3-(2-methoxy-4-nitrofenyl)-2-methylchinazolin-4-on | |||
| Pagoklon | 2-(7-chlor-1,8-naftyridin-2-yl)-2,3-dihydro-3-(5-methyl-2-oxohexyl)-1H-isoindol-1-on | |||
| Rilmazafon | 5-[[(2-aminoacetyl)amino]methyl]-1-[4-chlor-2-(2-chlorbenzoyl)fenyl]-N,N-dimethyl-1H-1,2,4-triazol-3-karboxamid | |||
| 3,4-CFP | 1-(3-chlor-4-fluorfenyl)piperazin | |||
| 4F-MBZP | 1-[(4-fluorfenyl)methyl]-4-methylpiperazin | |||
| pBPP | 1-(4-bromfenyl)piperazin | |||
| 4,4-Dimethyl-1-fenyl-1-pyrrolidin-1-yl-pentan-3-on | 4,4-dimethyl-1-fenyl-1-pyrrolidin-1-yl-pentan-3-on | |||
| Methyl 2-fenyl-2-(pyrrolidin-1-yl) acetát | methyl 2-fenyl-2-(pyrrolidin-1-yl)acetát | |||
| 3,5-ADB-4en-PFUPPYCA | N-(1-karbamoyl-2,2-dimethyl-propyl)-5-(4-fluorfenyl)-2-pent-4-enyl-pyrazol-3-karboxamid | |||
| 4en-PDMB-4en-PINACA | pent-4-en-1-yl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazol-3-karboxamido)-butanoát | |||
| 4F-ABINACA | N-(adamantan-1-yl)-1-(4-fluorbutyl)-1H-indazol-3-karboxamid | |||
| 5,3-AB-CHMFUPPYCA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyklohexylmethyl)-5-(4-fluorfenyl)-1H-pyrazol-3-karboxamid | |||
| 5,3-ADB-4en-PFUPPYCA | N-(1-karbamoyl-2,2-dimethyl-propyl)-5-(4-fluorfenyl)-1-pent-4-enyl-pyrazol-3-karboxamid | |||
| 5B-AKB48 | N-(1-adamantyl)-1-(5-brompentyl)indazol-3-karboxamid | |||
| 5F-BZO-POXIZID | N-[(Z)-[1-(5-fluorpentyl)-2-oxo-indolin-3-yliden]amino] benzamid | |||
| 5F-EDMB-PICA | ethyl 2-(1-(5-fluorpentyl)-1H-indol-3-karboxamido)-3,3-dimethylbutanoát | |||
| 5F-EMB-PICA | ethyl 2-[[1-(5-fluorpentyl)indol-3-karbonyl]amino]-3-methyl-butanoát | |||
| ABO-4en-PINACA | N-(1-amino-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazol-3-karboxamid | |||
| ADB-4en-P-5Br-INACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-brom-1-(pent-4-en-1-yl)-1H-indazol-3-karboxamid | |||
| ADB-4en-PINACA | N-(1-amino-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazol-3-karboxamid | |||
| ADB-5Br-INACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-brom-1H-indazol-3-karboxamid | |||
| ADB-B-5Br-INACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-brom-1-butyl-1H-indazol-3-karboxamid | |||
| ADB-D-5Br-INACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-brom-1-decyl-1H-indazol-3-karboxamid | |||
| ADB-FUBHQUCA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorfenyl)methyl-1,4-dihydrochinolin-3-karboxamid | |||
| ADB-FUBIACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorbenzyl)-1H-indol-3-acetamid | |||
| ADB-HEXINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-hexyl-1H-indazol-3-karboxamid | |||
| ADB-IACA | 2-[2-(1H-indol-3-yl)acetamido]-3,3-dimethylbutanamid | |||
| ADB-P-5Br-INACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-brom-1-pentyl-1H-indazol-3-karboxamid | |||
| ADMB-3TMS-PRINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(3-(trimethylsilyl)propyl)-1H-indazol-3-karboxamid | |||
| ADMB-INACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1H-indazol-3-karboxamid | |||
| A-FUBIACA | N-(1-adamantyl)-2-[1-[(4-fluorfenyl)methyl]indol-3-yl]acetamid | |||
| A-PBITMO | (adamantan-1-yl)(3-pentyl-2-thioxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)methanon | |||
| A-PONASA | N-adamantyl-4-(pentyloxy)naftalen-1-sulfonamid | |||
| BENZYL-4CN-BINACA | N-benzyl-1-(4-kyanobutyl)-1H-indazol-3-karboxamid | |||
| BZO-4en-POXIZID | N-[(Z)-(2-oxo-1-pent-4-enyl-indolin-3-yliden)amino]benzamid | |||
| BZO-POXIZID | N-[(Z)-(2-oxo-1-pentyl-indolin-3-yliden)amino]benzamid | |||
| CUMYL-1Cl-CHSINACA | 1-(1-chlorcyklohexyl)sulfonyl-N-(1-methyl-1-fenyl-ethyl)indazol-3-karboxamid | |||
| CUMYL-3TMS-PRINACA | N-(2-fenylpropan-2-yl)-1-(3-(trimethylsilyl)propyl)-1H-indazol-3-karboxamid | |||
| Cumyl-BC-HpMeGaClone-221 | (5-(bicyklo[2.2.1]hept-2-yl)methyl)-2-(2-fenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-on | |||
| Cumyl-CB-MeGaClone | 5-(cyklobutylmethyl)-2-(1-methyl-1-fenyl-ethyl)pyrido [4,3-b]indol-1-on | |||
| CUMYL-CBMICA | 1-(cyclobutylmethyl)-N-(2-fenylpropan-2-yl)-1H-indol-3-karboxamid | |||
| CUMYL-CBMINACA | 1-(cyklobutylmethyl)-N-(2-fenylpropan-2-yl)-1H-indazol-3-karboxamid | |||
| CUMYL-CHSINACA | 1-(cyklohexylsulfonyl)-N-(2-fenylpropan-2-yl)-1H-indazol-3-karboxamid | |||
| CUMYL-INACA | N-(2-fenylpropan-2-yl)-1H-indazol-3-karboxamid | |||
| CUMYL-NBMICA | 1-(bicyklo[2.2.1]heptan-2-ylmethyl)-N-(2-fenylpropan-2-yl)-1H-indol-3-karboxamid | |||
| CUMYL-NBMINACA | (1-(bicyklo[2.2.1]heptan-2-yl)methyl)-N-(2-fenylpropan-2-yl)-1H-indazol-3-karboxamid | |||
| CUMYL-TsINACA | N-(2-fenylpropan-2-yl)-1-tosyl-1H-indazol-3-karboxamid | |||
| EDMB-PINACA | ethyl 3,3-dimethyl-2-[(1-pentylindazol-3-karbonyl)amino] butanoát | |||
| FUBIAT | 1-[(4-fluorfenyl)methyl]-1H-indol-3-acetát | |||
| 10-hydroxy-HHC | (6aR,10R,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-hexahydro-6H-dibenzo[b,d]pyran-1,10-diol | |||
| 10-hydroxy-THC | (6aR,10R,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydro- benzo[c]chromen-1,10-diol | |||
| CH-FUBBMPDORA | N-{5-brom-1-[(4-fluorfenyl)methyl]-4-methyl-2-oxo-1,2-dihydropyridin-3-yl}cyklohexankarboxamid | |||
| CH-FUBIACA | N-cyklohexyl-2-(1-(4-fluorbenzyl)-1H-indol-3-yl)acetamid | |||
| CH-IACA | N-cyklohexyl-2-(1H-indol-3-yl)acetamid | |||
| CHM-MDA-19 (BZO-CHMOXIZID) | N-[(Z)-[1-(cyklohexylmethyl)-2-oxo-indolin-3-yliden] amino]benzamid | |||
| CHM-MDMB-CHMINACA | cyklohexylmethyl 2-(1-(cyklohexylmethyl)-1H-indazol-3-karboxamido)-3,3-dimethyl butanoát | |||
| CH-PIACA | N-cyklohexyl-2-(1-pentyl-1H-indol-3-yl)acetamid | |||
| MDMB-5Br-INACA | methyl 2-(5-brom-1H-indazol-3-karboxamido)-3,3-dimethylbutanoát | |||
| MDMB-7Br-INACA | methyl 2-(7-brom-1H-indazol-3-karboxamido)-3,3-dimethylbutanoát | |||
| MDMB-BINACA | methyl 2-(1-butyl-1H-indazol-3-karboxamido)-3,3-dimethylbutanoát | |||
| MDMB-CHMINACA | methyl 2-[1-(cyklohexylmethyl)-1H-indazol-3-karboxamido]-3,3-dimethylbutanoát | |||
| MDMB-INACA | methyl 2-(1H-indazol-3-karboxamido)-3,3-dimethylbutanoát | |||
| MDMB-PINACA | methyl 3,3-dimethyl-2-[(1-pentyl-1H-indazol-3-karbonyl)amino]butanoát | |||
| Muscimol | 5-(aminomethyl)-3(2H)-isoxazolon | S výjimkou nezpracovaných hub, v nichž se muscimol vyskytuje přirozeně. | ||
| NMDMSB | 1-naftyl 4-methyl-3-(dimethylsulfamoyl)-benzoát | |||
| PTI-3 | N-({2-[1-(5-fluorpentyl)-1H-indol-3-yl]-1,3-thiazol-4-yl}methyl)-2-methoxy-N-methyl ethanamin |
Including stereoisomers of psychoactive substances, except for the explicit exceptions listed in this list, in all cases where such stereoisomers may exist according to the specific chemical designation and salts and esters of psychoactive substances listed in this list in all cases where they may exist.
Sign in for notes, favorites and notifications
Regulation Information
| Citation | Government Decree No. 11 / 2025 Coll., on the List of Listed Psychoactive Substances |
|---|---|
| Regulation Type | - |
| Author | - |
| Collection | Code of Laws |
| Date of Promulgation | 16.01.2025 |
|---|---|
| Effective from | 17.01.2025 |
| Effective until | - |
| Status | Valid |
Public Contracts 2
Rámcová smlouva na ostatní chemické analýzy s VŠCHT pro celé SZPI
Státní zemědělská a potravinářská inspekce
Vysoká škola chemicko-technologická v Praze
2 030 906 CZK
12.12.2025
PŘÍKAZNÍ SMLOUVA O ZAJIŠTĚNÍ VÝKONU ČINNOSTI
MANAŽERA KYBERNETICKÉ BEZPEČNOSTI
Nemocnice Strakonice, a.s.
Jihočeské centrum kybernetické bezpečnosti s.r.o.
5 808 000 CZK
09.09.2025
Source:
Hlídač státu
(CC BY 3.0 CZ)
The regulation text is for informational purposes only.
Comments 0